Samsung Biologics workers initiated a general strike, affecting production operations from May 1 to May 5.

As Samsung Biologics is a crucial player in the biopharmaceutical industry, the strike could lead to shortages in medical treatments worldwide, affecting international healthcare systems.

Watch for statements from Samsung Biologics on the strike's impact, potential resolutions, and any response measures from health authorities or international partners.

South Korea's Ministry of Science and ICT unveiled a significant five-year investment plan to inject 1 trillion KRW into the AI sector.

This investment is critical in boosting South Korea's position as a global leader in AI, potentially driving economic growth and technological advancement.

Announcements of specific projects or partnerships within the initiative.

AstraZeneca announced a significant investment of £300 million in the UK, focusing on two sites, reversing previous plans to halt large-scale projects.

This investment signifies a major boost to the UK's pharmaceutical sector, potentially leading to increased job creation, innovation, and enhanced pharmaceutical capabilities in the region, impacting global supply chains.

Watch for detailed plans and timelines from AstraZeneca regarding the development of the two sites and any subsequent announcements from the UK government.